Latest updates you need to know, quick, clear, and to the point.
The Union Minister of Commerce and Industry, Shri Piyush Goyal, emphasized the Central Government’s commitment to supporting States...
The National Coordination Centre – Pharmacovigilance Programme of India (NCC-PvPI), Indian Pharmacopoeia Commission (IPC), participated in the tenth...
The National Health Authority (NHA), the implementing agency of Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) and...
The first (FENhance 2) of two pivotal RMS studies met its primary endpoint, showing investigational fenebrutinib significantly reduced...
The Ministry of Health and Family Welfare in alignment with the Government’s vision to promote equitable access to...
Phase III ALLEGORY study met primary and all key secondary endpoints with Gazyva/Gazyvaro, an anti-CD20 monoclonal antibody designed...
The Fourth Round (November 3-7, 2025) of negotiations for the India-New Zealand Free Trade Agreement (FTA) commenced today...
Findings further demonstrate the effectiveness of Roche’s approved medicines in advancing treatment standards for people with blood disorders...
https://www.who.int/news/item/31-10-2025-who-calls-for-a-new-era-of-strategic-urban-health-action-with-global-guide-to-unlock-healthy-prosperous-and-resilient-societies Geneva----On World Cities Day, the World Health Organization (WHO) calls on national and city leaders to transform...
OVERVIEW This is the 59th situation report for the multi-country outbreak of mpox, which provides details on the...
Basel, 30 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche’s wholly owned subsidiary...
https://www.who.int/news/item/29-10-2025-who-condemns-killings-of-patients-and-civilians-amid-escalating-violence-in-el-fasher--sudan Geneva/Cairo---The World Health Organization (WHO) condemns the reported killing of more than 460 patients and their companions,...